SureTrader SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Vericel Corp. (VCEL)

The PureGen osteoprogenitor cell allograft facilitates bone fusion,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
EZ2 Member Profile
Member Level Grandfathered Member
Followed By 201
Posts 202,792
Boards Moderated 7
Alias Born 03/31/01
160x600 placeholder
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 1/18/2017 5:16:47 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 1/4/2017 2:19:59 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 12/30/2016 4:10:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/30/2016 4:07:06 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 12/30/2016 4:04:26 PM
Vericel Corporation Announces Exercise of Underwriters’ Over-Allotment Option and Closing of $20 Million Offering of Common... "GlobeNewswire Inc." - 12/21/2016 4:05:00 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 12/19/2016 11:15:44 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/16/2016 5:31:05 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 12/16/2016 5:24:05 PM
Vericel Corporation Prices $17 Million Public Offering of Common Stock "GlobeNewswire Inc." - 12/16/2016 9:14:38 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 12/16/2016 6:03:31 AM
Vericel Corporation Announces Proposed Public Offering of Common Stock "GlobeNewswire Inc." - 12/15/2016 6:12:07 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/14/2016 12:12:09 PM
FDA Approves MACI for the Treatment of Symptomatic Cartilage Defects of the Knee in Adults "GlobeNewswire Inc." - 12/14/2016 7:10:27 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/29/2016 2:07:19 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/25/2016 6:02:44 AM
Vericel to Present at 28th Annual Piper Jaffray Healthcare Conference "GlobeNewswire Inc." - 11/22/2016 8:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/17/2016 4:19:30 PM
Additional Pre-Specified Secondary Results on the Reduction of Ventricular Arrhythmias Presented at AHA from Vericel’s Posi... "GlobeNewswire Inc." - 11/14/2016 2:00:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/7/2016 5:31:02 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/7/2016 4:36:49 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 11/3/2016 4:14:43 PM
Vericel to Host Third-Quarter 2016 Earnings Webcast and Conference Call on November 7, 2016 "GlobeNewswire Inc." - 10/31/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/11/2016 6:09:36 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/11/2016 6:06:13 AM
EZ2 Member Level Grandfathered Member Tuesday, 10/05/10 09:40:31 AM
Re: mkendra post# 2573
Post # of 5565 
Quote:
The PureGen osteoprogenitor cell allograft facilitates bone fusion, and is marketed exclusively by Alphatec Spine.

PureGen is an adult stem cell that provides cellular and growth factors needed for osteogenesis, without the potential complications of autograft.

Applied at the site of a musculoskeletal defect, PureGen mimics the regenerative environment of youthful tissues by increasing the concentration of stem cells available to repair tissue and build bone.



“There are those who don’t know and those who don’t know they don’t know.”

John Kenneth Galbraith
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist